Le Lézard
Classified in: Health
Subjects: PDT, WOM, DEI

FemiClear Launches Ground-Breaking Product for Bacterial Vaginosis Symptoms in Walgreens Stores Nationwide


AUSTIN, Texas, Nov. 29, 2022 /PRNewswire/ -- FemiClear, known for its ever-growing line of all-natural vaginal health products, announced its newest offering this week: a 2-day remedy for bacterial vaginosis symptoms. 

FemiClear Launches Ground-Breaking Product for Bacterial Vaginosis Symptoms in Walgreens Stores Nationwide

This remedy, which, like all its products, can be purchased over the counter, works quickly and is highly effective. With just a 2-day dose, it is proven to kill 99.9% of the bacteria that can cause bacterial vaginosis* and 91% of users reported their BV symptoms were eliminated**.

According to the Centers for Disease Control, Bacterial Vaginosis is the most common vaginal problem for women between the ages of 15 and 44. It's also uncomfortable, unpleasant, and can lead to long-term health issues if left untreated.  With this offering, women will have the ability to address their symptoms with a quick trip to their local Walgreens store.

Product Highlights:

FemiClear is on a mission to tackle taboo topics in women's health, creating over-the-counter products that are proven effective and made with all-natural ingredients. FemiClear's parent company, OrganiCare, is a women-led business founded in 2016, in Austin, Texas and has quickly become a leader in transforming the natural healthcare products industry, establishing a new benchmark in scientific rigor to prove efficacy in its products. To learn more about FemiClear and its family of products visit www.FemiClear.com.

*An independent accredited lab performed an in vitro (non-human/non-animal) time kill study to measure the amount of Gardnerella Vaginalis that was killed. An overgrowth of Gardnerella Vaginalis, can cause a bacterial vaginosis (BV) infection, but might not be the only cause. Data on file.

**As self-reported in a comprehensive IRB approved study of >100 women. Individual results may vary. Data on file.

SOURCE OrganiCare


These press releases may also interest you

at 20:45
The global liver cancer drugs market size is estimated to increase by USD 5.29 billion from 2021 to 2026. The market's growth momentum will accelerate at a CAGR of 14.67%. The report provides a comprehensive analysis of growth opportunities at...

at 20:40
Rare Cannabinoid Company has announced a special offer for customers to try their extra strength THCV gummies for appetite suppression and energy and CBD gummies for stress resilience. The premium Hawaiian company is encouraging cannabis and hemp...

at 20:35
Bioceres Crop Solutions Corp. (Bioceres) , a fully integrated provider of crop productivity solutions designed to enable the transition of agriculture towards carbon neutrality, announced financial results for the fiscal second quarter ended December...

at 20:21
GC Biopharma (006280.KS), a leading provider of biopharmaceutical products in South Korea, announced today that the World Health Organization (WHO) has awarded prequalification to filling and finish plant on February 3 2023, located in Ochang, South...

at 19:30
The "Whole Genome and Exome Sequencing Markets by Application, Organism and Product with Executive and Consultant Guides. Includes Direct to Consumer Analysis 2023 to 2027" report has been added to  ResearchAndMarkets.com's offering. The report...

at 19:15
The Medical Gas Blenders Market by Product and Geography - Forecast and Analysis 2022-2026 report has been published by Technavio. Market size is forecast to grow by USD 528.37 million between 2021 and 2026 at a CAGR of 5.44%. The report provides a...



News published on 29 november 2022 at 08:17 and distributed by: